Seminars
Jun 8, 2026
CryoCLEM and cryoET services at the EMBL Imaging Centre: best practices for high-throughput in situ structural biology
Speaker: Dr. Zhengyi Yang
European Molecular Biology Laboratory
School of Biomedical Sciences cordially invites you to join the following seminar:
Date: 8 June 2026 (Monday)
Time: 10:00 am – 11:00 am
Venue: Seminar Room 2, G/F, Laboratory Block, 21 Sassoon Road
Host: Professor Tao Ni
Biography
Dr. Yang is currently a senior cryoCLEM specialist in the European Molecular Biology Organisation (EMBO). He obtained his PhD in Physics in 2014 in the University of Dundee working on optical imaging, where he continued to work as a research fellow until 2017. After that he moved to Oxford, working in the National electron microscopy imaging centre (eBIC) until 2020, before joining EMBO. Dr Yangs current interest and expertise lies in the biological cryo-CLEM and tomography and has been dedicated to developing novel image acquisition and workflows to EMBL Imaging Center.
Abstract
Cryogenic correlative light and electron microscopy (cryoCLEM) and cryo-electron tomography (cryoET) enable structural studies of biological specimens in their native cellular context. At the EMBL Imaging Centre, we provide integrated cryoCLEM/ET workflows spanning sample preparation, vitrification, cryogenic fluorescence imaging, FIB milling, and TEM data acquisition. In this presentation, we highlight practical best practices developed through routine service operation, including optimized sample carriers, efficient screening strategies, improved cryo-FIB milling / cryo-liftout procedures, fluorescence-correlation workflows, and automated data collection pipelines. These approaches enhance targeting accuracy, throughput, reproducibility, and data quality, supporting reliable high-throughput in situ structural biology.
All are welcome.
New Releases
Jun 8, 2026
HKUMed School of Biomedical Sciences and Votee AI sign MoU to launch student internships and joint R&D in applied AI
May 28, 2026
HKUMed develops innovative tool to repair genetic errors, offering new hope for neurodegenerative diseases
Mar 9, 2026